Regen BioPharma, Inc.
RGBP
$0.01
$0.0020.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -242.20% | -762.37% | 96.24% | -90.40% | -108.07% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 562.16% | -158.73% | 0.00% | 130.00% | -1,076.74% |
| Total Other Non-Cash Items | -31.84% | -- | -100.00% | -97.37% | 7,496.15% |
| Change in Net Operating Assets | 115.33% | -276.83% | -121.92% | 568.70% | -86.23% |
| Cash from Operations | -185.71% | 44.66% | -52.41% | 67.97% | -20.10% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 113.57% | -45.58% | 56.38% | -15.10% | -- |
| Total Debt Repaid | -- | -- | -- | -- | 92.86% |
| Issuance of Common Stock | -- | -- | -- | -- | -79.16% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 306.79% | -45.58% | 56.38% | -54.99% | -6.46% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -100.00% | 366.67% | 99.02% | -274.85% |